Free Trial
NASDAQ:FONR

Fonar Q2 2024 Earnings Report

Fonar logo
$15.59 +0.13 (+0.84%)
As of 07/8/2025 04:00 PM Eastern

Fonar EPS Results

Actual EPS
$0.54
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Fonar Revenue Results

Actual Revenue
$25.39 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Fonar Announcement Details

Quarter
Q2 2024
Time
N/A
Conference Call Date
Wednesday, February 14, 2024
Conference Call Time
7:00AM ET

Upcoming Earnings

Fonar's Q4 2025 earnings is scheduled for Thursday, September 25, 2025, with a conference call scheduled on Friday, September 26, 2025 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Fonar Earnings Headlines

White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
Fonar (FONR)
Fonar Corporation Delays 10-Q Filing
See More Fonar Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Fonar? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fonar and other key companies, straight to your email.

About Fonar

Fonar (NASDAQ:FONR) (NASDAQ: FONR) is a medical technology company specializing in the development, manufacture and service of magnetic resonance imaging (MRI) systems. Founded in 1978 and headquartered in Melville, New York, the company offers a range of MRI solutions designed to provide high-resolution diagnostic imaging in both clinical and research settings. Fonar’s product line includes its signature Upright™ MRI scanners, which enable patients to be scanned in weight-bearing positions, as well as open and semi-open MRI units tailored to various clinical applications.

The company’s core activities encompass research and development, system production, sales, installation and ongoing maintenance of MRI equipment. Fonar invests in proprietary technologies aimed at enhancing image quality, reducing scan times and improving patient comfort. Its service division delivers nationwide and international support, including preventive maintenance, on-site repairs and remote technical assistance. Through distributor partnerships and direct sales efforts, Fonar has installed systems in hospitals, imaging centers and research institutions around the globe.

Fonar’s origins are closely tied to the pioneering work of its late founder, Dr. Raymond V. Damadian, who performed the world’s first full-body MRI scan and founded the company to commercialize the technology. Under Dr. Damadian’s leadership, Fonar received the first U.S. Food and Drug Administration clearance for a commercial MRI scanner in 1980, establishing a foundation for the widespread adoption of MRI as a noninvasive diagnostic tool. Over the decades, Fonar has continued to innovate, securing patents for its upright imaging capabilities and developing enhancements that address both spinal and musculoskeletal applications.

Today, Fonar is led by President and Chief Executive Officer Stephen R. Dwoskin, whose background in medical device finance and operations underpins the company’s growth strategies. Alongside a seasoned management team, Dwoskin focuses on expanding Fonar’s global footprint, advancing technology development and strengthening customer support networks. With its combination of specialized upright MRI platforms and comprehensive service offerings, Fonar remains a distinctive player in the medical imaging industry.

View Fonar Profile

More Earnings Resources from MarketBeat